biophBiomedical PhotonicsBiomedical Photonics2413-9432Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis10.24931/2413-9432-2023-13-1-47-55bioph-635Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSФoтoдинaмичecкaя тepaпия в лeчeнии BПЧ-accoцииpoвaннoгo paкa шeйки мaтки: мexaнизмы, пpo6лeмы и пepcпeктивы нa 6yдyщeePhotodynamic therapy in the treatment of HPV-associated cervical cancer: mechanisms, challenges and future prospectsШаназаровН. А.ShanazarovN. А.

Астана

Astana

ЗинченкоС. В.ZinchenkoS. V.

Казань

Kazan

zinchenkos.v@mail.ruКисиковаС. Д.KisikovaS. D.

Астана

Astana

РизвановА. А.RizvanovA. A.

Казань

Kazan

СмаиловаС.SmailovaS.

Астана

Astana

ПетуховК. А.PetukhovK. A.

Казань

Kazan

СалмаганбетоваЖ. Ж.SalmaganbetovaZh. Zh.

Астана

Astana

Больница Медицинского центра Управления делами Президента Республики КазахстанКазахстанHospital of the Medical Center of the Office of the President of the Republic of KazakhstanKazakhstanКазанский (Приволжский) федеральный университетРоссияKazan (Volga Region) Federal UniversityRussian Federation2024170520241314755Copyright © Шаназаров Н.А., Зинченко С.В., Кисикова С.Д., Ризванов А.А., Смаилова С., Петухов К.А., Салмаганбетова Ж.Ж., 20242024Шаназаров Н.А., Зинченко С.В., Кисикова С.Д., Ризванов А.А., Смаилова С., Петухов К.А., Салмаганбетова Ж.Ж.Shanazarov N.А., Zinchenko S.V., Kisikova S.D., Rizvanov A.A., Smailova S., Petukhov K.A., Salmaganbetova Z.Z.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pdt-journal.com/jour/article/view/635

Фoтoдинaмичecкaя тepaпия (ФДT) зapeкoмeндoвaлa ce6я кaк мнoгoo6eщaющий мeтoд лeчeния paкa шeйки мaтки, вызвaннoгo виpycoм пaпиллoмы чeлoвeкa (BПЧ). B этoм o6зope вcecтopoннe paccмaтpивaeтcя poль ФДT в пpeoдoлeнии пpo6лeм, cвязaнныx c тpaдициoнными мeтoдaми лeчeния paкa шeйки мaтки. Haчинaя c o6зopa взaимocвязи мeждy paкoм шeйки мaтки и BПЧ-инфeкциeй, в o6зope пpeдcтaвлeны пpинципы ФДT, мexaнизм ee дeйcтвия и ee пoтeнциaл в кaчecтвe иннoвaциoннoй cтpaтeгии лeчeния. B o6зope ocвeщeны дoклиничecкиe иccлeдoвaния нa живoтныx мoдeляx, кoтopыe дeмoнcтpиpyют эффeктивнocть ФДT в oтнoшeнии клeтoк шeйки мaтки, инфициpoвaнныx BПЧ и дaют пpeдcтaвлeниe o мexaнизмax ee цитoтoкcичecкoгo дeйcтвия. Mы paccмoтpeли клиничecкиe иccлeдoвaния и oтчeты o cлyчaяx, в кoтopыx пoдчepкивaeтcя пoтeнциaл ФДT кaк aльтepнaтивнoгo или дoпoлнитeльнoгo мeтoдa лeчeния. Пpo6лeмы и oгpaничeния, включaя глy6инy пpoникнoвeния cвeтa, cпeцифичнocтъ фoтoceнcи6илизaтopoв и cтaндapтизaцию пpoтoкoлoв, 6yдyт o6cyждaтьcя в кoнтeкcтe пoтeнциaлъныx пo6oчныx эффeктoв и cpaвнeния c тpaдициoнными мeтoдaми лeчeния.

Бyдyщиe нaпpaвлeния включaют тeкyщиe иccлeдoвaния, кoм6иниpoвaннyю тepaпию c иммyнoтepaпиeй или тapгeтными пpeпapaтaми, дocтижeния в paзpa6oткe фoтoceнcи6илизaтopoв и пepcoнaлизиpoвaнныe пoдxoды. Paзвитиe ФДT o6eщaeт измeнить пoдxoд к лeчeнию paкa шeйки мaтки, accoцииpoвaннoгo c BПЧ, зa cчeт o6ecпeчeния цeлeнaпpaвлeннoгo, пepcoнaлизиpoвaннoгo и минимaльнo инвaзивнoгo пoдxoдa.

Photodynamic therapy (PDT) has shown promise as a modality for the treatment of cervical cancer caused by the human papillomavirus (HPV). This review provides a comprehensive examination of the role of PDT in overcoming the challenges presented by conventional treatments for cervical cancer. Beginning with an overview of the relationship between cervical cancer and HPV infection, the review introduces the principles of PDT, its mechanism of action, and its potential as an innovative treatment strategy. The review highlights preclinical studies in animal models that demonstrate the efficacy of PDT in targeting HPV-infected cervical cells and provide mechanistic insights into its cytotoxic effects. We reviewed clinical studies and case reports highlighting the potential of PDT as an alternative or adjunctive treatment option. Challenges and limitations, including depth of light penetration, photosensitizer specificity, and standardization of protocols, will be discussed in the context of potential side effects and comparison with conventional treatments. Future directions include ongoing research, combination therapies with immunotherapy or targeted agents, advances in photosensitizer development, and personalized approaches. The advancement of PDT promises to change the landscape of HPV-associated cervical cancer treatment by providing a targeted, personalized, and minimally invasive approach.

paк шeйки мaткивиpyc пaпиллoмы чeлoвeкa (BПЧ)фoтoдинaмичecкaя тepaпия (ФДT)кoм6иниpoвaннaя тepaпияфoтoceнcи6илизaтopыcervical cancerhuman papillomavirus (HPV)photodynamic therapy (PDT)combination therapiesphotosensitizersReferencesBrancaleon, L., Moseley, H. Laser and Non-laser Light Sources for Photodynamic Therapy // Lasers Med Sci. – 2002. – Vol. 17. – P. 173-186.Brancaleon, L., Moseley, H. Laser and Non-laser Light Sources for Photodynamic Therapy. Lasers Med Sci, 2002, vol. 17, pp. 173-186.Fowler J.R., Maani E.V., Dunton C.J., Jack B.W. Cervical Cancer. 2022 Nov 2. In: StatPearls // Treasure Island (FL): StatPearls Publishing. – 2023. – P. 28613745.Fowler J.R., Maani E.V., Dunton C.J., Jack B.W. Cervical Cancer. 2022 Nov 2. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023, pp. 28613745.Okunade K.S. Human papillomavirus and cervical cancer // J Obstet Gynaecol. – 2020. – Vol. 40(5). – P. 602-608. doi: 10.1080/01443615.2019.1634030.Okunade K.S. Human papillomavirus and cervical can- cer. J Obstet Gynaecol, 2020, vol. 40(5), pp. 602-608. doi: 10.1080/01443615.2019.1634030.Sravani A.B., Ghate V., Lewis S. Human papillomavirus infection, cervical cancer and the less explored role of trace elements // Biol Trace Elem Res. – 2023. – Vol. 201(3). – P. 1026-1050. doi: 10.1007/s12011-022-03226-2.Sravani A.B., Ghate V., Lewis S. Human papillomavirus infection, cervical cancer and the less explored role of trace elements. Biol Trace Elem Res, 2023, vol. 201(3). pp.1026-1050. doi: 10.1007/ s12011-022-03226-2.Doorbar J., Egawa N., Griffin H., Kranjec C., Murakami I. (2016). Human papillomavirus molecular biology and disease association // Rev. Med. Virol. 25. – P. 2-23. doi: 10.1002/rmv.1822Doorbar J., Egawa N., Griffin H., Kranjec C., Murakami I. (2016). Human papillomavirus molecular biology and disease associa- tion. Rev. Med. Virol, vol. 25, pp. 2-23. doi: 10.1002/rmv.1822Serrano B., Brotons M., Bosch F. X., Bruni L. Epidemiology and burden of HPV related disease // Best Pract. Res. Clin. Obstet. Gynaecol. – 2017. – Vol. 47. – P. 14-26. doi: 10.1016/j.bpobgyn.2017.08.006Serrano B., Brotons M., Bosch F. X., Bruni L. Epidemiology and bur- den of HPV related disease. Best Pract. Res. Clin. Obstet. Gynaecol, 2017, vol. 47, pp. 14-26. doi: 10.1016/j.bpobgyn.2017.08.006Medda A., Duca D., Chiocca S. Human Papillomavirus and Cellular Pathways: Hits and Targets // Pathogens. – 2021. – Vol. 10(3). – P. 262. doi: 10.3390/pathogens10030262.Medda A., Duca D., Chiocca S. Human Papillomavirus and Cellular Pathways: Hits and Targets. Pathogens, 2021, vol. 10(3), pp. 262. doi: 10.3390/pathogens10030262.De Martel C., Plummer M., Vignat J., Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type Int // J. Cancer. – 2017. – Vol. 141. – P. 664-670. doi: 10.1002/ijc.30716De Martel C., Plummer M., Vignat J., Franceschi S. Worldwide bur- den of cancer attributable to HPV by site, country and HPV type Int. J. Cancer, 2017, vol. 141, pp. 664-670. doi: 10.1002/ijc.30716Van Straten D., Mashayekhi V., De Bruijn H.S., Oliveira S., Robinson D.J. Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions // Cancers (Basel). – 2017. – Vol. 9(2). – P. 18-19. doi: 10.3390/cancers9020019.Van Straten D., Mashayekhi V., De Bruijn H.S., Oliveira S., Robinson D.J. Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel), 2017, vol. 9(2), pp. 18-19. doi: 10.3390/cancers9020019.Afanasiev M.S., Dushkin A.D., Grishacheva T.G., Afanasiev S.S., Karaulov Academician A.V. Photodynamic therapy for early-stage cervical cancer treatment // Photodiagnosis Photodyn Ther. – 2022. – Vol. 37. – P. 102620. doi: 10.1016/j.pdpdt.2021.102620.Afanasiev M.S., Dushkin A.D., Grishacheva T.G., Afanasiev S.S., Karaulov Academician A.V. Photodynamic therapy for early-stage cervical cancer treatment. Photodiagnosis Photodyn Ther, 2022, vol. 37, pp. 102620. doi: 10.1016/j.pdpdt.2021.102620.Yoo J.O., Ha K.S. New insights into the mechanisms for photodynamic therapy-induced cancer cell death // Int Rev Cell Mol Biol. – 2012. – Vol. 295. – P. 139-74. doi: 10.1016/B978-0-12-394306-4.00010-1.Yoo J.O., Ha K.S. New insights into the mechanisms for photo- dynamic therapy-induced cancer cell death. Int Rev Cell Mol Bio, 2012, vol. 295, 139-74. doi: 10.1016/B978-0-12-394306-4.00010-1.Kwiatkowski S., Knap B., Przystupski D., Saczko J., Kędzierska E., Knap-Czop K., Kotlińska J., Michel O., Kotowski K., Kulbacka J. Photodynamic therapy mechanisms, photosensitizers and combinations // Biomed Pharmacother. – 2018. – Vol. 106. – P. 1098-1107. doi: 10.1016/j.biopha.2018.07.049.Kwiatkowski S., Knap B., Przystupski D., Saczko J., Kędzierska E., Knap-Czop K., Kotlińska J., Michel O., Kotowski K., Kulbacka J. Pho- todynamic therapy - mechanisms, photosensitizers and combina- tions, Biomed Pharmacother, 2018, vol. 106, pp. 1098-1107. doi: 10.1016/j.biopha.2018.07.049.Gunaydin G., Gedik M.E., Ayan S. Photodynamic Therapy for the Treatment and Diagnosis of Cancer-A Review of the Current Clinical Status // Front Chem. – 2021. – Vol. 9. – P. 686303. doi: 10.3389/fchem.2021.686303.Gunaydin G., Gedik M.E., Ayan S. Photodynamic Therapy for the Treatment and Diagnosis of Cancer-A Review of the Current Clinical Status. Front Chem, 2021, vol. 9, pp. 686303. doi: 10.3389/fchem.2021.686303.Ivanova V.A., Verenikina E.V., Nikitina V.P., et al. Photodynamic therapy for preinvasive cervical cancer // J Clin Oncol. – 2020. – Vol. 38. – P. 6035-6035.Ivanova V.A., Verenikina E.V., Nikitina V.P., et al. Photodynamic therapy for preinvasive cervical cancer. J Clin Oncol, 2020, vol. 38, pp. 6035-6035.Yang L., Shi P., Zhao G., Xu J., Peng W., Zhang J., Zhang G., Wang X., Dong Z., Chen F., Cui H. Targeting cancer stem cell pathways for cancer therapy // Signal Transduct Target Ther. – 2020. – Vol. 5(1). – P. 8. doi: 10.1038/s41392-020-0110-5.Yang L., Shi P., Zhao G., Xu J., Peng W., Zhang J., Zhang G., Wang X., Dong Z., Chen F., Cui H. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther, 2020, vol. 5(1), pp. 8. doi: 10.1038/s41392-020-0110-5.Chizenga E.P., Chandran R., Abrahamse H. Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells // Oncotarget. – 2019. – Vol. 10(43). – P. 43804396. doi: 10.18632/oncotarget.Chizenga E.P., Chandran R., Abrahamse H. Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervi- cal cancer stem cells. Oncotarget, 2019, vol. 10(43), pp. 4380-4396. doi: 10.18632/oncotarget.Doorbar J., Egawa N., Griffin H., Kranjec C., Murakami I. Human papillomavirus molecular biology and disease association // Rev. Med. Virol. – 2016. – Vol. 25. – P.2-23. doi: 10.1002/rmv.1822Doorbar J., Egawa N., Griffin H., Kranjec C., Murakami I. Human papillomavirus molecular biology and disease association. Rev. Med. Virol, 2016, vol. 25, pp. 2-23. doi: 10.1002/rmv.1822Serrano B., Brotons M., Bosch F. X., Bruni L. Epidemiology and burden of HPV related disease // Best Pract. Res. Clin. Obstet. Gynaecol. – 2017. – Vol. 47. – P.14-26. doi: 10.1016/j.bpobgyn.2017.08.006Serrano B., Brotons M., Bosch F. X., Bruni L. Epidemiology and bur- den of HPV related disease. Best Pract. Res. Clin. Obstet. Gynaecol, 2017, vol. 47, pp. 14-26. doi: 10.1016/j.bpobgyn.2017.08.006Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide // J Pathol. – 1999. – Vol. 189. – P.12-19.Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999, vol. 189, pp. 12-19.Yeo-Teh N.S.L., Ito Y., Jha S. High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis // Int. J. Mol. Sci. – 2018. – Vol. 19. – P.1706. doi: 10.3390/ijms19061706.Yeo-Teh N.S.L., Ito Y., Jha S. High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis. Int. J. Mol. Sci, 2018, vol. 19, pp.1706. doi: 10.3390/ijms19061706.Oh S.T., Longworth M.S., Laimins L.A. Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11 // J Virol. – 2004. – Vol. 78(5). – P. 2620-2626. doi: 10.1128/jvi.78.5.2620-2626.2004.Oh S.T., Longworth M.S., Laimins L.A. Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol, 2004, vol. 78(5), pp. 2620-2626. doi: 10.1128/jvi.78.5.2620-2626.2004.Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. Oncoprotein E6, encoded by human papillomavirus types 16 and 18, contributes to the degradation of p53 // Cell. – 1990. – Vol. 63. – P. 1129-1136. doi: 10.1016/0092-8674(90)90409-8.Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. Oncoprotein E6, encoded by human papillomavirus types 16 and 18, contributes to the degradation of p53. Cell, 1990, vol. 63, pp. 1129-1136. doi: 10.1016/0092-8674(90)90409-8.Hudelist G., Manavi M., Pischinger K.I., Watkins-Riedel T., Singer C.F., Kubista E., Czerwenka K.F. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade // Gynecol Oncol. – 2004. – Vol. 92(3). – P. 873-80. doi: 10.1016/j.ygyno.2003.11.035.Hudelist G., Manavi M., Pischinger K.I., Watkins-Riedel T., Singer C.F., Kubista E., Czerwenka K.F. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol, 2004, vol. 92(3), pp.873-80. doi: 10.1016/j.ygyno.2003.11.035.Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions // J Gen Virol. – 1997. – Vol. 78(5). – P. 1095-101. doi: 10.1099/0022-1317-78-5-1095.Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervi- cal intraepithelial neoplastic lesions. J Gen Virol, 1997, vol. 78(5), pp.1095-101. doi: 10.1099/0022-1317-78-5-1095.Koshiol J., Lindsay L., Pimenta J.M., Poole C., Jenkins D., Smith J.S. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis // Am J Epidemiol. – 2008. – Vol. 168(2). – P.123-37. doi: 10.1093/aje/kwn036.Koshiol J., Lindsay L., Pimenta J.M., Poole C., Jenkins D., Smith J.S. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol, 2008, vol. 168(2), pp. 123-37. doi: 10.1093/aje/kwn036.Prendiville W., Sankaranarayanan R. Colposcopy and Treatment of Cervical Precancer // Lyon (FR): International Agency for Research on Cancer. – 2017. – Vol. 45.Prendiville W., Sankaranarayanan R. Colposcopy and Treatment of Cervical Precancer. Lyon (FR): International Agency for Research on Cancer, 2017, vol. 45.Grade Squamous Intraepithelial Lesions with High-Risk HPV Infection: A non-randomized, controlled pilot study // Photodiagnosis Photodyn Ther. – 2021. – P. 102548. doi: 10.1016/j.pdpdt.2021.102548.Grade Squamous Intraepithelial Lesions with High-Risk HPV Infection: A non-randomized, controlled pilot study. Photo- diagnosis Photodyn Ther, 2021. pp. 102548. doi: 10.1016/j.pdpdt.2021.102548.Bodner K., Bodner-Adler B., Wierrani F., Kubin A., Szölts-Szölts J., Spängler B., Grünberger W. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results // Anticancer Res. – 2003. – Vol. 23(2C). – P. 1785-1788.Bodner K., Bodner-Adler B., Wierrani F., Kubin A., Szölts-Szölts J., Spängler B., Grünberger W. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res, 2003, vol. 23(2C), pp.1785-1788.Lange N., Szlasa W., Saczko J., Chwiłkowska A. Potential of Cyanine Derived Dyes in Photodynamic Therapy // Pharmaceutics. – 2021. – Vol. 13(6). – P. 818. doi: 10.3390/pharmaceutics13060818.Lange N., Szlasa W., Saczko J., Chwiłkowska A. Potential of Cyanine Derived Dyes in Photodynamic Therapy. Pharmaceutics, 2021, vol. 13(6), pp. 818. doi: 10.3390/pharmaceutics13060818.Calixto G.M., Bernegossi J., de Freitas L.M., Fontana C.R., Chorilli M. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review // Molecules. – 2016. – Vol. 21(3). – P. 342. doi: 10.3390/molecules21030342.Calixto G.M., Bernegossi J., de Freitas L.M., Fontana C.R., Chorilli M. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules, 2016, vol. 21(3), pp.342. doi: 10.3390/molecules21030342.O’Connor A.E., Gallagher W.M., Byrne A.T. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. – 2009. – Vol. 85(5). – P. 1053-74. doi: 10.1111/j.1751-1097.2009.00585.x.O’Connor A.E., Gallagher W.M., Byrne A.T. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol, 2009, vol. 85(5), pp.1053-74. doi: 10.1111/j.1751-1097.2009.00585.x.Wilson B.C., Patterson M.S., Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm // Lasers Med Sci. – 1997. – Vol. 12(3). – P. 182-99. doi: 10.1007/BF02765099.Wilson B.C., Patterson M.S., Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm. Lasers Med Sci, 1997, vol. 12(3), pp. 182-99. doi: 10.1007/BF02765099.McIlroy B.W., Mann T.S., Dysart J.S., Wilson B.C. The effects of oxygenation and photosensitizer substrate binding on the use of fluorescence photobleaching as a dose metric for photodynamic therapy // Vib. Spectrosc. – 2002. – Vol. 28. – P. 25-35. doi: 10.1016/ S0924-2031(01)00159-X.McIlroy B.W., Mann T.S., Dysart J.S., Wilson B.C. The effects of oxygenation and photosensitizer substrate binding on the use of fluorescence photobleaching as a dose metric for photodynamic therapy. Vib. Spectrosc, 2002, vol. 28, pp. 25-35. doi: 10.1016/S0924-2031(01)00159-X.Turan I.S., Yildiz D., Turksoy A., Gunaydin G., Akkaya E.U. A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light // Angew Chem Int Ed Engl. – 2016. – Vol. 55(8). – P. 28752878. doi: 10.1002/anie.201511345.Turan I.S., Yildiz D., Turksoy A., Gunaydin G., Akkaya E.U. A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light. Angew Chem Int Ed Engl, 2016, vol. 55(8), pp. 2875-2878. doi: 10.1002/anie.201511345.Karaman O., Almammadov T., Emre Gedik M., Gunaydin G., Kolemen S., Gunbas G. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells // ChemMedChem. – 2019. – Vol. 14 (22). – P. 18791886. doi: 10.1002/cmdc.201900380Karaman O., Almammadov T., Emre Gedik M., Gunaydin G., Kolemen S., Gunbas G. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells, ChemMedChem, 2019, vol. 14 (22), pp. 1879-1886. 10.1002/cmdc.201900380Li W.P., Yen C.J., Wu B.S., Wong T.W. Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine // Biomedicines. – 2021. – Vol. 9. – P. 69. doi: mdpi.com/2227-9059/9/1/69Li W.P., Yen C.J., Wu B.S., Wong T.W. Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine. Biomedicines, 2021, vol. 9, pp. 69. https://www.mdpi.com/2227-9059/9/1/69Wang S., Dai X.Y., Ji S., Saeidi T., Schwiegelshohn F., Yassine A.A., Lilge L., Betz V. Scalable and accessible personalized photodynamic therapy optimization with FullMonte and PDT-SPACE // J Biomed Opt. – 2022. – Vol. 27(8). – P. 083006. doi: 10.1117/1.JBO.27.8.083006.Wang S., Dai X.Y., Ji S., Saeidi T., Schwiegelshohn F., Yassine A.A., Lilge L., Betz V. Scalable and accessible personalized photodynamic therapy optimization with FullMonte and PDT-SPACE. J Biomed Opt, 2022, vol. 27(8), pp. 083006. doi: 10.1117/1.JBO.27.8.083006.Algorri J.F., Ochoa M., Roldán-Varona P., Rodríguez-Cobo L, LópezHiguera JM. Photodynamic Therapy: A Compendium of Latest Reviews // Cancers (Basel). – 2021. – Vol. 13(17). – P. 4447. doi: 10.3390/cancers13174447.Algorri J.F., Ochoa M., Roldán-Varona P., Rodríguez-Cobo L, LópezHiguera JM. Photodynamic Therapy: A Compendium of Latest Reviews. Cancers (Basel), 2021, vol. 13(17), pp. 4447. doi: 10.3390/cancers13174447.Rakhimzhanova R.I., Shanazarov N.A., Turzhanova D.E. Photodynamic therapy of intradermal metastatic breast cancer (literature review) // Biomedical Photonics. – 2019. – Vol. 8(3). – P. 36-42. doi: 10.24931/2413–9432–2019–8-3-36-42.Rakhimzhanova R.I., Shanazarov N.A., Turzhanova D.E. Photodynamic therapy of intradermal metastatic breast cancer (literature review). Biomedical Photonics, 2019, vol. 8(3), pp. 36-42. doi: 10.24931/2413–9432–2019–8-3-36-42.Bilyalov A.I., Shanazarov N.A. & Zinchenko S.V. Photodynamic Therapy as Alternative Method of Treatment of Metastatic Ovarian Cancer with Many Recurrence: Case Report // BioNanoSci. – 2020. – P. 807-810. https://doi.org/10.1007/s12668-020-00749-7Bilyalov A.I., Shanazarov N.A. & Zinchenko S.V. Photodynamic Therapy as Alternative Method of Treatment of Metastatic Ovarian Cancer with Many Recurrence: Case Report. BioNanoSci, 2020, pp. 807-810. https://doi.org/10.1007/s12668-020-00749-7Shanazarov N., Zinchenko S., Zhapparov E. et al. The Clinical Case of Successful Application of Photodynamic Therapy in the Skin Metastases Treatment of Breast Cancer // BioNanoSci. – 2021. – Vol. 11. – P. 957-961. doi.org/10.1007/s12668-021-00907-5Shanazarov N., Zinchenko S., Zhapparov E. et al. The Clinical Case of Successful Application of Photodynamic Therapy in the Skin Metastases Treatment of Breast Cancer. BioNanoSci, 2021, vol. 11, pp. 957-961. doi.org/10.1007/s12668-021-00907-5Shanazarov N., Benberin V., Zinchenko S., Nalgieva F., Muratov N., Isahanova B., Tashpulatov T. Possibilities of Photodynamic Therapy in the Treatment of Multiple Cylindroma of the Scalp: The Clinical Case Study // Electron J Gen Med. – 2022. – Vol. 19(1). doi.org/10.29333/ejgm/11580Shanazarov N., Benberin V., Zinchenko S., Nalgieva F., Muratov N., Isahanova B., Tashpulatov T. Possibilities of Photodynamic Therapy in the Treatment of Multiple Cylindroma of the Scalp: The Clinical Case Study. Electron J Gen Med, 2022, vol. 19(1). doi.org/10.29333/ejgm/11580Filonenko E.V., Ivanova-Radkevich V.I. Photodynamic therapy of psoriasis // Biomedical Photonics. – 2023. – Vol. 12(1). – P. 28-36. doi: 10.24931/2413–9432–2023–12-1-28-36.Filonenko E.V., Ivanova-Radkevich V.I. Photodynamic therapy of psoriasis. Biomedical Photonics, 2023, vol. 12(1), pp. 28-36. doi: 10.24931/2413–9432–2023–12-1-28-36.Filonenko E.V., Ivanova-Radkevich V.I. Photodynamic therapy of acne // Biomedical Photonics. – 2023. – Vol. 12(2). – P. 48-53. doi: 10.24931/2413–9432–2023–12-2-48-56Filonenko E.V., Ivanova-Radkevich V.I. Photodynamic therapy of acne. Biomedical Photonics, 2023, vol. 12(2), pp. 48-53. doi: 10.24931/2413–9432–2023–12-2-48-56.Sokolov V. V. et al. Combination of fluorescence imaging and local spectrophotometry in fluorescence diagnostics of early cancer of larynx and bronchi //Quantum Electronics. – 2002. – Vol. 32(11). – C. 963.Sokolov V. V. et al. Combination of fluorescence imaging and local spectrophotometry in fluorescence diagnostics of early cancer of larynx and bronchi. Quantum Electronics, 2002, Vol. 32(11), pp. 963.Filonenko E. V. The history of development of fluorescence diagnosis and photodynamic therapy and their capabilities in oncology // Russian Journal of General Chemistry. – 2015. – Vol. 85(1). – P. 211-216.Filonenko E.V. The history of development of fluorescence diagnosis and photodynamic therapy and their capabilities in oncology. Russian Journal of General Chemistry, 2015, vol. 85(1), pp. 211-216.Zharkova N.N., Kozlov D.N., Smirnov V.V. et al. Fluorescence observations of patients in the course of photodynamic therapy of cancer with the photosensitizer PHOTOSENS // Proceedings of SPIE – Photodynamic Therapy of Cancer II. – 1995. – Vol. 2325. – P. 400403. doi: 10.1117/12.199176Zharkova N.N., Kozlov D.N., Smirnov V.V. et al. Fluorescence observations of patients in the course of photodynamic therapy of cancer with the photosensitizer PHOTOSENS, Proceedings of SPIE Photodynamic Therapy of Cancer II, 1995, vol. 2325, pp. 400-403. doi: 10.1117/12.199176Chissov, V.I., Skobelkin O.K., Mironov A.F. et al. Photodynamic therapy and fluorescent diagnosis of malignant tumors with the preparation photogem // Khirurgiya. – 1994. – Vol. 70(12). – p. 3-6.Chissov, V.I., Skobelkin O.K., Mironov A.F. et al. Photodynamic therapy and fluorescent diagnosis of malignant tumors with the preparation photogem. Khirurgiya, 1994, Vol. 70(12), pp. 3-6.

The authors declare that there are no conflicts of interest present.